Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.

Research Square 2026 Preprint Open access

Read full text
Authors: James Riley, Mosha Z. Deng, Tanishk Sinha, Meizan Lai, Shuguang Jiang, Hong Kong, Vincent Cooper, Meidi Gu, Jonah Perelman, Caimei Zhang, Chiquita Hanindya, Victor H. Carpio
+23 more Peter Keller, Julie K. Jadlowsky, Rachel M. Leskowitz, Stephen McKenna, Megan Four, J. M. González Barranco, Natalie A. Cooper, Ankita Jain, Mercy Gohil, Kathleen M. Haines, Laura Garcia-Gerique, Athena Russell, Irina M. Kulikovskaya, Vanessa E. Gonzalez, Joseph A. Fraietta, Gabriela Plesa, Neil C. Sheppard, Megan M. Suhoski, Anne Chew, Noelle V. Frey, Carl H. June, Jakub Svoboda, Elizabeth Olson Hexner
DOI: 10.21203/rs.3.rs-8436008/v1
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Immunotherapy and Immune Responses T-cell and B-cell Immunology

Publication details

Journal / source
Research Square
Publication date
4 February 2026
Language
EN
Document type
Preprint